The Unternehmens-Allianz [alliance of companies] researches as yet unknown effects of known medications
IMS Health Deutschland and Qlaym Healthcare collaborate
Everybody has heard of aspirin. Many of the effects which are known today, such as the protection against heart attacks and strokes, were only discovered as time went by as a result of chance observations after the initial market introduction. A strong alliance of companies with headquarters in Frankfurt and Göttingen is now searching for precisely these unknown effects of known medications in a structured manner.
QLAYM OPENS OPPORTUNITIES FOR ALL
QLAYM works with organizations across all areas – simply because big data opens opportunities for leaders in business, government and academia. We offer our clients solutions focused on their specific projects aimed at delivering substantial impact for their business. Every time. Commercially. Scientifically.
Above, we have partnered with world-leading companies by applying our technology and expertise to their complex data problems.
Applications POWERED BY QLAYM.
Q-USDTM – THE TARGETED COGNITION ENGINE
Today’s institutions and companies have to handle large amounts of complex, information-rich data. They know that this data contains valuable knowledge; knowledge they cannot overlook because it is the key to staying competitive. However they often do not have the tools to tap into this resource themselves.
Exactly this is what we do best. Our Q-USDTM technology has been designed to deal with the entire scope of challenges inherent to information-rich data generated by any organization. As a “cognition engine” it detects the key systematics that have predictive value in view of a predefined issue. Q-USDTM works fully data-driven and thus, with complete neutrality – only obligated to the purpose of delivering a payable outcome for our client.
LEARN MORE ABOUT OUR TECHNOLOGY